Transcriptome analysis of sinensetin-treated liver cancer cells guided by biological network analysis
- Authors:
- Seong Min Kim
- Shailima Rampogu
- Preethi Vetrivel
- Apoorva M. Kulkarni
- Sang Eun Ha
- Hun Hwan Kim
- Keun Woo Lee
- Gon Sup Kim
-
Affiliations: Research Institute of Life Science and College of Veterinary Medicine, Gyeongsang National University, Jinju, Gyeongsangnam 52828, Republic of Korea, Division of Life Science, Division of Applied Life Science (BK21 Plus), Plant Molecular Biology and Biotechnology Research Center, Research Institute of Natural Science, Gyeongsang National University, Jinju, Gyeongsangnam 52828, Republic of Korea - Published online on: March 4, 2021 https://doi.org/10.3892/ol.2021.12616
- Article Number: 355
-
Copyright: © Kim et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Li J, Fu Y, Hu X and Xiong Y: Psoralidin inhibits the proliferation of human liver cancer cells by triggering cell cycle arrest, apoptosis and autophagy and inhibits tumor growth in vivo. J BUON. 24:1950–1955. 2019.PubMed/NCBI | |
|
Sakin A, Sahin S, Atci MM, Yasar N, Geredeli C, Aribal S, Alemdar A, Karataş F and Cihan S: Factors affecting survival in patients with isolated liver-metastatic colorectal cancer treated with local ablative or surgical treatments for liver metastasis. J BUON. 24:1801–1808. 2019.PubMed/NCBI | |
|
Zhang X, Lv J, Luo H, Liu Z, Xu C, Zhou D, Tang L, Zhang Z, Liu J, Xiao M, et al: Nucleostemin promotes hepatocellular carcinoma by regulating the function of STAT3. Exp Cell Res. 387:1117482020. View Article : Google Scholar : PubMed/NCBI | |
|
Xu L, Wang R, Ziegelbauer J, Wu WW, Shen RF, Juhl H, Zhang Y, Pelosof L and Rosenberg AS: Transcriptome analysis of human colorectal cancer biopsies reveals extensive expression correlations among genes related to cell proliferation, lipid metabolism, immune response and collagen catabolism. Oncotarget. 8:74703–74719. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Y, Lv X, Yang G, Zhan J, Li M, Long T, Ho CT and Li S: Simultaneous separation of six pure polymethoxyflavones from sweet orange peel extract by high performance counter current chromatography. Food Chem. 292:160–165. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kang SI, Shin HS and Kim SJ: Sinensetin enhances adipogenesis and lipolysis by increasing cyclic adenosine monophosphate levels in 3T3-L1 adipocytes. Biol Pharm Bull. 38:552–558. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yu T, Zhang H and Qi H: Transcriptome profiling analysis reveals biomarkers in colon cancer samples of various differentiation. Oncol Lett. 16:48–54. 2018.PubMed/NCBI | |
|
Luo J, Dai X, Hu H, Chen J, Zhao L, Yang C, Sun J, Zhang L, Wang Q, Xu S, et al: Fluzoparib increases radiation sensitivity of non-small cell lung cancer (NSCLC) cells without BRCA1/2 mutation, a novel PARP1 inhibitor undergoing clinical trials. J Cancer Res Clin Oncol. 146:721–737. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lin KH, Huang MY, Cheng WC, Wang SC, Fang SH, Tu HP, Su CC, Hung YL, Liu PL, Chen CS, et al: RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment. Sci Rep. 8:26722018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang D, Zhao L, Wang D, Liu J, Yu X, Wei Y and Ouyang Z: Transcriptome analysis and identification of key genes involved in 1-deoxynojirimycin biosynthesis of mulberry (Morus alba L.). PeerJ. 6:e54432018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Kang Z, Lv D, Zhang X, Liao Y, Li Y, Liu R, Li P, Tong M, Tian J, et al: Longitudinal whole-genome sequencing reveals the evolution of MPAL. Cancer Genet. 240:59–65. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Niemira M, Collin F, Szalkowska A, Bielska A, Chwialkowska K, Reszec J, Niklinski J, Kwasniewski M and Kretowski A: Molecular signature of subtypes of non-small-cell lung cancer by large-scale transcriptional profiling: Identification of key modules and genes by Weighted Gene Co-Expression Network Analysis (WGCNA). Cancers (Basel). 12:E372019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z, Zhang Z, Zhang C and Xu Y: Identification of potential pathogenic biomarkers in clear cell renal cell carcinoma. Oncol Lett. 15:8491–8499. 2018.PubMed/NCBI | |
|
Stark R, Grzelak M and Hadfield J: RNA sequencing: The teenage years. Nat Rev Genet. 20:631–656. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Gu HY, Zhu J, Niu YM, Zhang C and Guo GL: Identification of hub genes and key pathways associated with bipolar disorder based on weighted gene co-expression Network Analysis. Front Physiol. 10:10812019. View Article : Google Scholar : PubMed/NCBI | |
|
Trapnell C, Pachter L and Salzberg SL: TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics. 25:1105–1111. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ and Pachter L: Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 28:511–515. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Benjamini Y, Drai D, Elmer G, Kafkafi N and Golani I: Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 125:279–284. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al: STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Supek F, Bošnjak M, Škunca N and Šmuc T: REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One. 6:e218002011. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SM, Ha SE, Ho JL, Rampogu S, Vetrivel P, Kim HH, Saralamma VVG, Lee KW and Kim GS: Sinensetin Induces Autophagic Cell Death through p53-Related AMPK/mTOR Signaling in Hepatocellular Carcinoma HepG2 Cells. Nutrients. 12:24622020. View Article : Google Scholar | |
|
Xiong H, Guo H, Xie Y, Zhao L, Gu J, Zhao S, Li J and Liu L: RNAseq analysis reveals pathways and candidate genes associated with salinity tolerance in a spaceflight-induced wheat mutant. Sci Rep. 7:27312017. View Article : Google Scholar : PubMed/NCBI | |
|
Livingstone C: IGF2 and cancer. Endocr Relat Cancer. 20:R321–R339. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Macaulay VM: Insulin-like growth factors and cancer. Br J Cancer. 65:311–320. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Guerra FK, Eijan AM, Puricelli L, Alonso DF, Bal de Kier Joffé E, Kornblihgtt AR, Charreau EH and Elizalde PV: Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability. Int J Cancer. 65:812–820. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Lin SB, Hsieh SH, Hsu HL, Lai MY, Kan LS and Au LC: Antisense oligodeoxynucleotides of IGF-II selectively inhibit growth of human hepatoma cells overproducing IGF-II. J Biochem. 122:717–722. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Martinez-Quetglas I, Pinyol R, Dauch D, Torrecilla S, Tovar V, Moeini A, Alsinet C, Portela A, Rodriguez-Carunchio L, Solé M, et al: IGF2 Is up-regulated by epigenetic mechanisms in hepatocellular carcinomas and is an actionable oncogene product in experimental models. Gastroenterology. 151:1192–1205. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Andreasen PA, Kjøller L, Christensen L and Duffy MJ: The urokinase-type plasminogen activator system in cancer metastasis: A review. Int J Cancer. 72:1–22. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Hundsdorfer B, Zeilhofer HF, Bock KP, Dettmar P, Schmitt M and Horch HH: The prognostic importance of urinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in the primary resection of oral squamous cell carcinoma. Mund Kiefer Gesichtschir. 8:173–179. 2004.(In German). PubMed/NCBI | |
|
Annecke K, Schmitt M, Euler U, Zerm M, Paepke D, Paepke S, von Minckwitz G, Thomssen C and Harbeck N: uPA and PAI-1 in breast cancer: Review of their clinical utility and current validation in the prospective NNBC-3 trial. Adv Clin Chem. 45:31–45. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Harbeck N, Schmitt M, Paepke S, Allgayer H and Kates RE: Tumor-associated proteolytic factors uPA and PAI-1: Critical appraisal of their clinical relevance in breast cancer and their integration into decision-support algorithms. Crit Rev Clin Lab Sci. 44:179–201. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Vairaktaris E, Yapijakis C, Psyrri A, Spyridonidou S, Yannopoulos A, Lazaris A, Vassiliou S, Ferekidis E, Vylliotis A, Nkenke E, et al: Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis. Anticancer Res. 27:979–984. 2007.PubMed/NCBI | |
|
Li L, Zhu Z, Zhao Y, Zhang Q, Wu X, Miao B, Cao J and Fei S: FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics. Sci Rep. 9:78272019. View Article : Google Scholar : PubMed/NCBI | |
|
Yu XM, Jaskula-Sztul R, Georgen MR, Aburjania Z, Somnay YR, Leverson G, Sippel RS, Lloyd RV, Johnson BP and Chen H: Notch1 signaling regulates the aggressiveness of differentiated thyroid cancer and inhibits SERPINE1 expression. Clin Cancer Res. 22:3582–3592. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng Q, Tang ZY, Xue Q, Shi DR, Song HY and Tang HB: Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor. J Cancer Res Clin Oncol. 126:641–646. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Divella R, Mazzocca A, Gadaleta C, Simone G, Paradiso A, Quaranta M and Daniele A: Influence of plasminogen activator inhibitor-1 (SERPINE1) 4G/5G polymorphism on circulating SERPINE-1 antigen expression in HCC associated with viral infection. Cancer Genomics Proteomics. 9:193–198. 2012.PubMed/NCBI | |
|
Holm M, Saraswat M, Joenväärä S, Ristimäki A, Haglund C and Renkonen R: Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics. PLoS One. 13:e01953542018. View Article : Google Scholar : PubMed/NCBI | |
|
Berger HR, Creech MK, Hannoush Z, Watanabe Y, Kargi A and Weiss RE: A novel mutation causing complete thyroid binding globulin deficiency (Tbg-Cd Mia) in a male with coexisting graves disease. AACE Clin Case Rep. 3:e134–e139. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Falanga A, Marchetti M and Vignoli A: Coagulation and cancer: Biological and clinical aspects. J Thromb Haemost. 11:223–233. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Adams GN, Rosenfeldt L, Frederick M, Miller W, Waltz D, Kombrinck K, McElhinney KE, Flick MJ, Monia BP, Revenko AS, et al: Colon cancer growth and dissemination relies upon thrombin, stromal PAR-1, and fibrinogen. Cancer Res. 75:4235–4243. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ciereszko A, Dietrich MA, Słowińska M, Nynca J, Ciborowski M, Kisluk J, Michalska-Falkowska A, Reszec J, Sierko E and Nikliński J: Identification of protein changes in the blood plasma of lung cancer patients subjected to chemotherapy using a 2D-DIGE approach. PLoS One. 14:e02238402019. View Article : Google Scholar : PubMed/NCBI | |
|
Dowling P, Palmerini V, Henry M, Meleady P, Lynch V, Ballot J, Gullo G, Crown J, Moriarty M and Clynes M: Transferrin-bound proteins as potential biomarkers for advanced breast cancer patients. BBA Clin. 2:24–30. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Wang F, Huang Y, Ke K, Zhao B, Chen L, Liao N, Wang L, Li Q, Liu X, et al: FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition. Cancer Manag Res. 11:1653–1665. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lee YS, Choi JW, Hwang I, Lee JW, Lee JH, Kim AY, Huh JY, Koh YJ, Koh GY, Son HJ, et al: Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation. J Biol Chem. 285:22174–22185. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Li F, Yu Z, Chen P, Lin G, Li T, Hou L, Du Y and Tan W: The increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer. Am J Cancer Res. 6:331–340. 2016.PubMed/NCBI | |
|
Ayyub A, Saleem M, Fatima I, Tariq A, Hashmi N and Musharraf SG: Glycosylated alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker. Int J Biochem Cell Biol. 70:68–75. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Rucksaken R, Charoensuk L, Pinlaor P, Pairojkul C, Khuntikeo N and Pinlaor S: Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma. Cancer Biomark. 18:27–34. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Falleti E, Pirisi M, Fabris C, Bortolotti N, Soardo G, Toniutto P, Gonano F and Bartoli E: Increase of serum alpha 1-acid glycoprotein despite the decline of liver synthetic function in cirrhotics with hepatocellular carcinoma. Eur J Clin Chem Clin Biochem. 31:407–411. 1993.PubMed/NCBI | |
|
Alexander H, Stegner AL, Wagner-Mann C, Du Bois GC, Alexander S and Sauter ER: Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res. 10:7500–7510. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, et al: Identification of a nuclear receptor that is activated by farnesol metabolites. Cell. 81:687–693. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G and Gonzalez FJ: Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell. 102:731–744. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J and Mangelsdorf DJ: Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell. 6:507–515. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
You W, Chen B, Liu X, Xue S, Qin H and Jiang H: Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1. Sci Rep. 7:5912017. View Article : Google Scholar : PubMed/NCBI | |
|
Guan B, Li H, Yang Z, Hoque A and Xu X: Inhibition of farnesoid X receptor controls esophageal cancer cell growth in vitro and in nude mouse xenografts. Cancer. 119:1321–1329. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Guo F, Xu Z, Zhang Y, Jiang P, Huang G, Chen S, Lyu X, Zheng P, Zhao X, Zeng Y, et al: FXR induces SOCS3 and suppresses hepatocellular carcinoma. Oncotarget. 6:34606–34616. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Adams JC and Lawler J: The thrombospondins. Int J Biochem Cell Biol. 36:961–968. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Huang T, Wang L, Liu D, Li P, Xiong H, Zhuang L, Sun L, Yuan X and Qiu H: FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1. Int J Oncol. 50:1501–1512. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Firlej V, Mathieu JR, Gilbert C, Lemonnier L, Nakhlé J, Gallou-Kabani C, Guarmit B, Morin A, Prevarskaya N, Delongchamps NB, et al: Thrombospondin-1 triggers cell migration and development of advanced prostate tumors. Cancer Res. 71:7649–7658. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Perez-Janices N, Blanco-Luquin I, Tuñón MT, Barba-Ramos E, Ibáñez B, Zazpe-Cenoz I, Martinez-Aguillo M, Hernandez B, Martínez-Lopez E, Fernández AF, et al: EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas. Oncotarget. 6:368–380. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Nie S, Lo A, Wu J, Zhu J, Tan Z, Simeone DM, Anderson MA, Shedden KA, Ruffin MT and Lubman DM: Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. J Proteome Res. 13:1873–1884. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lyu T, Jia N, Wang J, Yan X, Yu Y, Lu Z, Bast RC Jr, Hua K and Feng W: Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma. Epigenetics. 8:1330–1346. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Poon RT, Chung KK, Cheung ST, Lau CP, Tong SW, Leung KL, Yu WC, Tuszynski GP and Fan ST: Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma. Clin Cancer Res. 10:4150–4157. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Hayashi K, Kurohiji T and Shirouzu K: Localization of thrombospondin in hepatocellular carcinoma. Hepatology. 25:569–574. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Lee TK, Cheung VC, Lu P, Lau EY, Ma S, Tang KH, Tong M, Lo J and Ng IO: Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma. Hepatology. 60:179–191. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Tórsdóttir G, Gudmundsson G, Kristinsson J, Snaedal J and Jóhannesson T: Ceruloplasmin and superoxide dismutase (SOD1) in heterozygotes for Wilson disease: A case control study. Neuropsychiatr Dis Treat. 5:55–59. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Schapira DV and Schapira M: Use of ceruloplasmin levels to monitor response to therapy and predict recurrence of breast cancer. Breast Cancer Res Treat. 3:221–224. 1983. View Article : Google Scholar : PubMed/NCBI | |
|
Brandi J, Dalla Pozza E, Dando I, Biondani G, Robotti E, Jenkins R, Elliott V, Park K, Marengo E, Costello E, et al: Secretome protein signature of human pancreatic cancer stem-like cells. J Proteomics. 136:1–12. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Han IW, Jang JY, Kwon W, Park T, Kim Y, Lee KB and Kim SW: Ceruloplasmin as a prognostic marker in patients with bile duct cancer. Oncotarget. 8:29028–29037. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Upadhya S, Upadhya S and Prabhu KS: Serum glycoconjugates and ceruloplasmin in cancer of uterine cervix. Indian J Clin Biochem. 17:20–24. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Arumanayagam M, Wong FW, Rogers M and Swaminathan R: Serum ceruloplasmin, plasma copper concentration and copper to ceruloplasmin ratio in cervical carcinoma. Gynecol Obstet Invest. 35:175–178. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Huang L, Yoneda M and Kimata K: A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor. J Biol Chem. 268:26725–26730. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Chatterji B and Borlak J: A 2-DE MALDI-TOF study to identify disease regulated serum proteins in lung cancer of c-myc transgenic mice. Proteomics. 9:1044–1056. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Heo SH, Lee SJ, Ryoo HM, Park JY and Cho JY: Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics. 7:4292–4302. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Chong PK, Lee H, Zhou J, Liu SC, Loh MC, Wang TT, Chan SP, Smoot DT, Ashktorab H, So JB, et al: ITIH3 is a potential biomarker for early detection of gastric cancer. J Proteome Res. 9:3671–3679. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Pertea M: The human transcriptome: An unfinished story. Genes (Basel). 3:344–360. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Cajigas-Du Ross CK, Martinez SR, Woods-Burnham L, Durán AM, Roy S, Basu A, Ramirez JA, Ortiz-Hernández GL, Ríos-Colón L, Chirshev E, et al: RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance. Oncotarget. 9:30363–30384. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao S, Fung-Leung WP, Bittner A, Ngo K and Liu X: Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells. PLoS One. 9:e786442014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Z, Li B, Xu P and Yang B: Integrated whole transcriptome profiling and bioinformatics analysis for revealing regulatory pathways associated with quercetin-induced apoptosis in HCT-116 cells. Front Pharmacol. 10:7982019. View Article : Google Scholar : PubMed/NCBI | |
|
Xiong YJ, Deng ZB, Liu JN, Qiu JJ, Guo L, Feng PP, Sui JR, Chen DP and Guo HS: Enhancement of epithelial cell autophagy induced by sinensetin alleviates epithelial barrier dysfunction in colitis. Pharmacol Res. 148:1044612019. View Article : Google Scholar : PubMed/NCBI | |
|
Forni C, Facchiano F, Bartoli M, Pieretti S, Facchiano A, D'Arcangelo D, Norelli S, Valle G, Nisini R, Beninati S, et al: Beneficial role of phytochemicals on oxidative stress and age-related diseases. BioMed Res Int. 2019:87482532019. View Article : Google Scholar : PubMed/NCBI |
